P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 226,257 shares at $336.87 ($74.2M) on 2018-06-21, disclosed to the SEC on 2018-06-22.
Seasonal sale ($74.2M) by Chairman of the Board — this insider has traded REGN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 557 | $0 | 0.0% |
| 2 | $0.00 | 616 | $0 | 0.0% |
| 3 | $333.07 | 78,564 | $26.2M | 35.3% |
| 4 | $323.97 | 400 | $130K | 0.2% |
| 5 | $323.97 | 400 | $130K | 0.2% |
| 6 | $324.18 | 500 |
| $162K |
| 0.2% |
| 7 | $325.67 | 8,047 | $2.6M | 3.5% |
| 8 | $325.67 | 8,047 | $2.6M | 3.5% |
| 9 | $326.57 | 15,594 | $5.1M | 6.9% |
| 10 | $326.57 | 15,594 | $5.1M | 6.9% |
| 11 | $327.48 | 19,393 | $6.4M | 8.6% |
| 12 | $327.48 | 19,393 | $6.4M | 8.6% |
| 13 | $328.45 | 12,426 | $4.1M | 5.5% |
| 14 | $328.45 | 12,426 | $4.1M | 5.5% |
| 15 | $329.51 | 12,854 | $4.2M | 5.7% |
| 16 | $329.51 | 12,854 | $4.2M | 5.7% |
| 17 | $330.32 | 3,096 | $1.0M | 1.4% |
| 18 | $330.32 | 3,096 | $1.0M | 1.4% |
| 19 | $331.09 | 100 | $33K | 0.0% |
| 20 | $332.80 | 1,300 | $433K | 0.6% |
| 21 | $333.15 | 500 | $167K | 0.2% |
| 22 | $335.01 | 300 | $101K | 0.1% |
| 23 | $336.87 | 200 | $67K | 0.1% |
| Total | $327.93 avg | 226,257 | $74.2M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |